Clinical trials: Cheek Augmentation
Cheek Augmentation
Study to Evaluate Satisfaction After Treatment With Restylane
Open-label, phase IV, post-marketing study to evaluate aesthetic improvement and satisfaction after treatment with Restylane
- Trial name
- NCT04638816
- Testing
- Restylane Volyme, Restylane Lyft Lidocaine
- Where
- 3 sites in Canada
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Galderma R&D
Mid-facial Volume Deficit Related to Aging
Safety and Effectiveness of Juvéderm® VOLUMA XC Injectable Gel for Cheek Augmentation
Multicenter, single-blind, randomized, "no-treatment" control study to demonstrate the safety and effectiveness of VOLUMA XC for deep injection for cheek augmentation to correct age-related volume deficit in the mid-face.
- Trial name
- NCT00978042
- Testing
- Juvéderm® VOLUMA XC
- Where
- 2 sites in United States, Canada
- Volunteers
- 345 people, healthy volunteers welcome
- Sponsor
- Allergan
Facial Tissue Augmentation
Evaluation of Efficacy and Safety of Hyaluronic Acid (HA) Product for Cheek Augmentation
A multi-centre, evaluator-blinded study in subjects undergoing cheek augmentation. The study is designed to assess efficacy with regard to aesthetic midface augmentation and safety after treatment with HA product.
- Trial name
- NCT02396251
- Testing
- HA experimental, HA comparator
- Where
- 2 sites in Sweden
- Volunteers
- 48 people, healthy volunteers welcome
- Sponsor
- Galderma R&D
Age-related Volume Deficit in the Mid-face
A Study of the Safety and Effectiveness of JUVÉDERM VOLUMA® XC Injectable Gel for Cheek Augmentation Using Cannula
The objective of this study is to evaluate the safety and effectiveness of JUVÉDERM VOLUMA® XC injectable gel using cannula in participants seeking correction of age-related volume deficit in the mid-face.
- Trial name
- NCT03438266
- Testing
- JUVÉDERM VOLUMA® XC injectable gel with cannula, JUVÉDERM VOLUMA® XC injectable gel with needle
- Where
- 7 sites in United States
- Volunteers
- 66 people
- Sponsor
- Allergan
Cheek Augmentation, Correction of Age-related Midface Contour Deficiencies
RHA®4 for Midface Volume Deficiency
This is a prospective, randomized, controlled, blinded evaluator, multicenter, between subjects clinical study to identify whether RHA4 is non-inferior to a comparator device for treatment of midface volume deficiency 8 weeks…
- Trial name
- NCT05133739
- Testing
- injection of RHA®4 in Midface, injection of Comparator Product in Midface
- Where
- United States
- Volunteers
- 201 people, healthy volunteers welcome
- Sponsor
- Teoxane SA
Cheek Augmentation
GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies
An interventional study to evaluate the safety and effectiveness of GAL1704 for cheek augmentation and the correction of midface volume deficiencies by demonstrating non-inferiority in change from baseline, relative to an active…
- Trial name
- NCT03700047
- Testing
- GAL1704, Juvederm Voluma
- Where
- 15 sites in United States
- Volunteers
- 270 people, healthy volunteers welcome
- Sponsor
- Galderma R&D
Cheek Augmentation, Midface Contour Deficiencies
Injection Technique Assessment of Restylane Lyft With Lidocaine for Cheek Augmentation
This is a multi-center, open-label, single-arm study to evaluate an injection tool with Restylane Lyft with Lidocaine for cheek augmentation and correction of age related midface contour deficiencies.
- Trial name
- NCT03160716
- Testing
- Restylane Lyft with Lidocaine
- Where
- 4 sites in United States
- Volunteers
- 60 people, healthy volunteers welcome
- Sponsor
- Galderma R&D
Facial Tissue Augmentation
A Study of Treatment Preference During Cheek Contouring Comparing Restylane® SubQ With and Without the Addition of Lidocaine Hydrochloride
The objectives of this study are to evaluate the pain-relieving effect and safety of adding lidocaine hydrochloride to Restylane SubQ and to evaluate the esthetic improvement obtained.
- Trial name
- NCT01431755
- Testing
- Restylane SubQ, Restylane SubQ Lidocaine
- Where
- 3 sites in Sweden
- Volunteers
- 54 people, healthy volunteers welcome
- Sponsor
- Galderma R&D